Mt. Vernon man fights pancreatic cancer with innovative drug

Pancreatic cancer, which accounts for about 2 percent of new cancer diagnoses each year, is among the deadliest forms of the disease, but now there may be hope for some patients.

For Tom Martin, of Mount Vernon, it has been a long road from a Nov. 2009 diagnosis. Martin says his disease was caught in the early stages and doctors felt he was an ideal candidate for a clinical trial involving a new chemotherapy treatment that's getting incredible results.

Dr. Robert Fine, the medical oncology director at the Pancreas Center at NewYork-Presbyterian Hospital/Columbia University Medical Center, developed what's called the three-drug GTX regiment.

"When you give them together... they synergize multiple ways with each other, so they can kill drug resistant cells, which is very common in pancreatic cancer," Fine says.

In the past six months, Martin has gone through seven cycles of the GTX regiment, and underwent his eighth and final round today.

Doctors say Martin's recent tests indicate his cancer is in remission, but he will have to undergo tests every few months to ensure the cancer remains in remission.

sorry to interrupt
your first 20 are free
Access to News 12 is free for Optimum, Comcast®, Time Warner® and Service ElectricSM customers.
Please enjoy 20 complimentary views of articles, photos, and videos during the next 30 days.
you have reached your 5 view limit
Access to News 12 is free for Optimum, Comcast®, Time Warner® and Service ElectricSM customers.
Please login, create an account or subscribe to continue enjoying News12.
Our sign-up page is undergoing maintenance and is not currently available. However, you will be given direct access to news12.com while we complete our upgrade.
When we are back up and running you will be prompted at that time to complete your sign in. Until then, enjoy the local news, weather, traffic and more that's "as local as local news gets."